158 related articles for article (PubMed ID: 29457930)
1. Nano-loaded human umbilical cord mesenchymal stem cells as targeted carriers of doxorubicin for breast cancer therapy.
Cao S; Guo J; He Y; Alahdal M; Tang S; Zhao Y; Yang Z; Gao H; Hu W; Jiang H; Qin L; Jin L
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):642-652. PubMed ID: 29457930
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of angiogenic effects by hypoxia-preconditioned human umbilical cord-derived mesenchymal stem cells in a mouse model of hindlimb ischemia.
Han KH; Kim AK; Kim MH; Kim DH; Go HN; Kim DI
Cell Biol Int; 2016 Jan; 40(1):27-35. PubMed ID: 26222206
[TBL] [Abstract][Full Text] [Related]
3. Molecular imaging for assessment of mesenchymal stem cells mediated breast cancer therapy.
Leng L; Wang Y; He N; Wang D; Zhao Q; Feng G; Su W; Xu Y; Han Z; Kong D; Cheng Z; Xiang R; Li Z
Biomaterials; 2014 Jun; 35(19):5162-70. PubMed ID: 24685267
[TBL] [Abstract][Full Text] [Related]
4. Transferrin-inspired vehicles based on pH-responsive coordination bond to combat multidrug-resistant breast cancer.
He YJ; Xing L; Cui PF; Zhang JL; Zhu Y; Qiao JB; Lyu JY; Zhang M; Luo CQ; Zhou YX; Lu N; Jiang HL
Biomaterials; 2017 Jan; 113():266-278. PubMed ID: 27842254
[TBL] [Abstract][Full Text] [Related]
5. Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment.
Cui T; Zhang S; Sun H
Oncol Rep; 2017 Feb; 37(2):1253-1260. PubMed ID: 28075466
[TBL] [Abstract][Full Text] [Related]
6. [Protective Effects of Intraventricular Transplanted Human Umbilical Cord-derived Mesenchymal Stem Cells on Hypoxic Ischemic Brain Damages in Rats].
Fan X; Bai XH; Chen J; Wan Q; Chen Q; Mu DZ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 48(2):179-185. PubMed ID: 28612523
[TBL] [Abstract][Full Text] [Related]
7. Modified methods of nanoparticles synthesis in pH-sensitive nano-carriers production for doxorubicin delivery on MCF-7 breast cancer cell line.
Hamidu A; Mokrish A; Mansor R; Razak ISA; Danmaigoro A; Jaji AZ; Bakar ZA
Int J Nanomedicine; 2019; 14():3615-3627. PubMed ID: 31190815
[No Abstract] [Full Text] [Related]
8. Human umbilical cord mesenchymal stem cells ameliorate mice trinitrobenzene sulfonic acid (TNBS)-induced colitis.
Liang L; Dong C; Chen X; Fang Z; Xu J; Liu M; Zhang X; Gu DS; Wang D; Du W; Zhu D; Han ZC
Cell Transplant; 2011; 20(9):1395-408. PubMed ID: 21396175
[TBL] [Abstract][Full Text] [Related]
9. Human Umbilical Cord Mesenchymal Stem Cells Promote Breast Cancer Metastasis by Interleukin-8- and Interleukin-6-Dependent Induction of CD44(+)/CD24(-) Cells.
Ma F; Chen D; Chen F; Chi Y; Han Z; Feng X; Li X; Han Z
Cell Transplant; 2015; 24(12):2585-99. PubMed ID: 25695620
[TBL] [Abstract][Full Text] [Related]
10. In vivo magnetic resonance imaging tracking of SPIO-labeled human umbilical cord mesenchymal stem cells.
Hu SL; Lu PG; Zhang LJ; Li F; Chen Z; Wu N; Meng H; Lin JK; Feng H
J Cell Biochem; 2012 Mar; 113(3):1005-12. PubMed ID: 22065605
[TBL] [Abstract][Full Text] [Related]
11. EphA2-positive human umbilical cord-derived mesenchymal stem cells exert anti-fibrosis and immunomodulatory activities via secretion of prostaglandin E2.
Wen YC; Du MK; Li MW; Hsuan YC; Su YC; Lin W
Taiwan J Obstet Gynecol; 2018 Oct; 57(5):722-725. PubMed ID: 30342659
[TBL] [Abstract][Full Text] [Related]
12. Actively targeting D-α-tocopheryl polyethylene glycol 1000 succinate-poly(lactic acid) nanoparticles as vesicles for chemo-photodynamic combination therapy of doxorubicin-resistant breast cancer.
Jiang D; Gao X; Kang T; Feng X; Yao J; Yang M; Jing Y; Zhu Q; Feng J; Chen J
Nanoscale; 2016 Feb; 8(5):3100-18. PubMed ID: 26785758
[TBL] [Abstract][Full Text] [Related]
13. Nano-Engineered Mesenchymal Stem Cells Increase Therapeutic Efficacy of Anticancer Drug Through True Active Tumor Targeting.
Layek B; Sadhukha T; Panyam J; Prabha S
Mol Cancer Ther; 2018 Jun; 17(6):1196-1206. PubMed ID: 29592881
[TBL] [Abstract][Full Text] [Related]
14. The Effects of Indoxyl Sulfate on Human Umbilical Cord-Derived Mesenchymal Stem Cells In Vitro.
Wang W; Liu X; Wang W; Li J; Li Y; Li L; Wang S; Zhang J; Zhang Y; Huang H
Cell Physiol Biochem; 2016; 38(1):401-14. PubMed ID: 26824459
[TBL] [Abstract][Full Text] [Related]
15. Nano-engineered mesenchymal stem cells as targeted therapeutic carriers.
Sadhukha T; O'Brien TD; Prabha S
J Control Release; 2014 Dec; 196():243-51. PubMed ID: 25456830
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of FOXQ1 enhances anti-senescence and migration effects of human umbilical cord mesenchymal stem cells in vitro and in vivo.
Zhang T; Wang P; Liu Y; Zhou J; Shi Z; Cheng K; Huang T; Wang X; Yang GL; Yang B; Ma S; Guan F
Cell Tissue Res; 2018 Aug; 373(2):379-393. PubMed ID: 29500491
[TBL] [Abstract][Full Text] [Related]
17. Robust, active tumor-targeting and fast bioresponsive anticancer nanotherapeutics based on natural endogenous materials.
Sun B; Deng C; Meng F; Zhang J; Zhong Z
Acta Biomater; 2016 Nov; 45():223-233. PubMed ID: 27576338
[TBL] [Abstract][Full Text] [Related]
18. Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats.
Koh SH; Kim KS; Choi MR; Jung KH; Park KS; Chai YG; Roh W; Hwang SJ; Ko HJ; Huh YM; Kim HT; Kim SH
Brain Res; 2008 Sep; 1229():233-48. PubMed ID: 18634757
[TBL] [Abstract][Full Text] [Related]
19. Human Umbilical Cord Mesenchymal Stem Cells: Subpopulations and Their Difference in Cell Biology and Effects on Retinal Degeneration in RCS Rats.
Wang L; Li P; Tian Y; Li Z; Lian C; Ou Q; Jin C; Gao F; Xu JY; Wang J; Wang F; Zhang J; Zhang J; Li W; Tian H; Lu L; Xu GT
Curr Mol Med; 2017; 17(6):421-435. PubMed ID: 29210653
[TBL] [Abstract][Full Text] [Related]
20. Decreased intracellular pH induced by cariporide differentially contributes to human umbilical cord-derived mesenchymal stem cells differentiation.
Gao W; Zhang H; Chang G; Xie Z; Wang H; Ma L; Han Z; Li Q; Pang T
Cell Physiol Biochem; 2014; 33(1):185-94. PubMed ID: 24481225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
